40188-45-2,
2-Acetyl-4-butyramidophenol,
N-(3-Acetyl-4-hydroxyphenyl)butyramide,
Ac-HoPhe-OH,
N-(3-Acetyl-4-hydroxyphenyl)butanamide,
UNII-14QJB65R4V,
3'-Acetyl-4'-hydroxybutyranilide,
14QJB65R4V,
Butanamide, N-(3-acetyl-4-hydroxyphenyl)-,
5'-Butyramido-2'-hydroxyacetophenone,
MFCD00798556,
EINECS 254-831-0,
Acebutolol Impurity C,
n-(3-acetyl-4-hydroxyphenyl)butanamid,
AC1LEHVU,
AC1Q5DER,
ACMC-20ao67,
EC 254-831-0,
2-Acetyl 4-butyramidophenol,
DSSTox_CID_31526,
DSSTox_RID_97411,
Acebutolol Impurity C (EP),
DSSTox_GSID_57737,
3-Acetyl-4-hydroxybutyranilide,
SCHEMBL7569662,
CHEMBL3184751,
DTXSID7057737,
CTK3J6444,
FGWZEOPEZISTTR-UHFFFAOYSA-N,
ZINC157213,
EBD37109,
Tox21_113821,
SBB058421,
AKOS000121374,
MCULE-7194034794,
NE11699,
VZ23475,
KS-000010E0,
NCGC00253700-01,
5-BUTYRAMIDO-2-HYDROXYACETOPHENONE,
AC-15462,
AJ-14949,
Q422,
SC-75519,
ZB006604,
N-(3-acetyl-4-hydroxyphenyl)-bu-tanamide,
CAS-40188-45-2,
DB-049547,
N-(3-ethanoyl-4-oxidanyl-phenyl)butanamide,
RT-003020,
TL8002910,
FT-0639620,
ST24048334,
ST50407044,
EN300-16642,
N-(3-Acetyl-4-hydroxyphenyl)butanamide, 97%,
A824966,
SR-01000058746,
SR-01000058746-1,
W-106380,
Z56347249,
Acebutolol impurity C, European Pharmacopoeia (EP) Reference Standard,
Acebutolol Related Compound A, United States Pharmacopeia (USP) Reference Standard,
N-(3-Acetyl-4-hydroxyphenyl)butyramide; 5'-Butyramido-2'-hydroxyacetophenone,
C12H15NO3,
AR-1J8389,
C12-H15-N-O3,
CID736331,
ZINC00157213,
4042-61-9,